Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8+ CMV-specific cytotoxic T lymphocytes

Experimental Hematology

Volumn 34, Issue 3, 2006, Pages 296-307

  Lim, Jong Baeck ^a   Provenzano, Maurizio ^b   Kwon, Oh Hun ^a   Bettinotti, Maria ^b   Caruccio, Lorraine ^b   Nagorsen, Dirk ^c   Stroncek, David ^b  

^a Yonsei University College of Medicine   (South Korea)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; MATRIX PROTEIN; MESSENGER RNA; PEPTIDE; PHOSPHOPROTEIN; SER VAL ASN VAL HIS ASN PRO THR GLY ARG; UNCLASSIFIED DRUG;

ALGORITHM; AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL POPULATION; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY TEST; IMMUNOTHERAPY; IN VITRO STUDY; MEMORY T LYMPHOCYTE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TARGET CELL; VIRUS INFECTIVITY;

AMINO ACID SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES; FLOW CYTOMETRY; HLA-A ANTIGENS; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VIRAL MATRIX PROTEINS;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS;

EID: 33644884175     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.12.006     Document Type: Article

References (37)

1. J.M. Goodrich, R.A. Bowden, L. Fisher, C. Keller, G. Schoch, and J.D. Meyers Ganciclovir prophylaxis to prevent cytomegalovirus infection after allogeneic marrow transplant Ann Intern Med 118 1993 173 178
2. J. Taylor-Wiedeman, P. Sissons, and J. Sinclair Introduction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers J Virol 68 1994 1597 1604
3. K. Kondo, J. Xu, and E.S. Mocarski Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in sero-positive individuals Proc Natl Acad Sci U S A 93 1996 11137 11142
4. H. Einsele, H. Hebart, and C. Kauffmann-Schneider Risk factors for treatment failure in patients receiving PCR-based preemptive antiviral therapy for CMV infection Bone Marrow Transplant 25 2000 757 763
5. S. Szmania, A. Galloway, and M. Bruorton Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers Blood 98 2001 505 512
6. E.C. Reed, R.A. Bowden, P.S. Dandliker, K.E. Lilleby, and J.D. Meyers Treatment of cytomegalovirus pneumonia with gancyclovir and intravenous immunoglobulin in patients with bone marrow transplant Ann Intern Med 109 1988 783 788
7. M. Boeckh, R.A. Bowden, T. Gooley, D. Myerson, and L. Corey Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients Blood 93 1999 1781 1782
8. P. Reusser, C. Cordonnier, and H. Einsele for the infectious Disease Working Party of the European Group for Blood and Marrow Transplantation (EMBT). European survey of herpes virus resistance to antiviral drugs in bone marrow transplant recipients Bone Marrow Transplant 17 1996 813 817
9. L.K. Borysiewicz, S. Graham, J.K. Hickling, P.D. Mason, and J.G. Sissons Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity Eur J Immunol 18 1988 269 275
10. P. Reusser, S.R. Riddell, J.D. Meyers, and P.D. Greenberg Cytotoxic T lymphocyte response to cytomegalovirus following human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease Blood 78 1991 1373 1380
11. E.A. Walter, P.D. Greenberg, and M.J. Gilbert Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor N Engl J Med 333 1995 1038 1044
12. H. Einsele, E. Roosnek, and N. Rufer Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy Blood 99 2002 3916 3922
13. K.S. Peggs, and S. Mackinnon Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy Hum Immunol 65 2004 550 557
14. K. Peggs, S. Verfuerth, and S. Mackinnon Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions Blood 97 2001 994 1000
15. B. Carlsson, W.S. Cheng, T.H. Totterman, and M. Essand Ex vivo stimulation of cytomegalovirus (CMV)-specific T cells using CMV pp65-modified dendritic cells as stimulators Br J Haematol 121 2003 428 438
16. + T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants Blood 103 2004 3565 3572
17. + virus-specific cytotoxic T lymphocytes J Med Virol 43 1994 103 110
18. M.R. Wills, A.J. Carmichael, and K. Mynard The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL J Virol 70 1996 7569 7579
19. F. Kern, I.P. Surel, and C. Brock T-cell epitope mapping by flow cytometry Nat Med 4 1998 975 978
20. + T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides Eur J Immunol 30 2000 1676 1682
21. *0201 restricted peptide-based vaccine against human cytomegalovirus infection Blood 90 1997 1751 1767
22. *0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus J Immunol 163 1999 5512 5518
23. + T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay Blood 98 2001 1872 1881
24. M. Provenzano, S. Mocellin, and M. Bettinotti Identification of immune dominant cytomegalovirus epitopes using quantitative real-time polymerase chain reactions to measure interferon-γ production by peptide-stimulated peripheral blood mononuclear cells J Immunother 25 2002 342 351
25. J.A. Zaia, J.G. Patrick Sissons, and S. Riddell Status of cytomegalovirus prevention and treatment in 2000. Hematology (Am Soc Hematol Educ Program) 2000 339 355
26. M.H. Park, Y.S. Hwang, and K.S. Park HLA haplotypes in Koreans based on 107 families Tissue Antigens 51 1998 347 355
27. T.D. Lee Distribution of HLA antigens in North American Caucasians, North American Blacks and Orientals J. Lee The HLA System, A New Approach 1990 Springer-Verlag New York Inc New York 141 178
28. K.C. Parker, M.A. Bednarek, and J.E. Coligan Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains J Immunol 152 1994 163 175
29. M.S. Chee, A.T. Bankier, and S. Beck Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169 Curr Top Microbiol Immun 154 1990 125 169
30. M. Provenzano, S. Mocellin, and P. Bonginelli Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR) J Transl Med 15 2003 12 23
31. U.S. Kammula, F.M. Marincola, and S.A. Rosenberg Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination J Natl Cancer Inst 92 2000 1336 1344
32. S.A. Bustin Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays J Mol Endocrinol 25 2000 169 193
33. S.A. Bustin Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems J Mol Endocrinol 29 2002 23 39
34. *2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides Clin Cancer Res 15 2004 2645 2651
35. A.R. Neves, L.F. Ensina, and L.B. Anselmo Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-γ in mixed lymphocyte reactions Cancer Immunol Immunother 54 2005 61 66
36. K.O. Falk, S. Rotzschke, and V. Stevanovic Analysis of a naturally occurring HLA class I-restricted viral epitope Immunology 82 1994 337 342
37. C.A. Singer, X.A. Figueroa-Masot, R.H. Batchelor, and D.M. Dorsa The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons J Neurosci 19 1999 2455 2463